Advertisement

Cataract Surgery and Diabetic Retinopathy

  • David J. Browning
Chapter

Abstract

Diabetes mellitus is increasing around the world with 171 million affected persons in 2000 and projected prevalences of 221 and 366 million affected patients by 2010 and 2030, respectively.,2 In the United States, an estimated 7.8% of the population has diabetes.3 Diabetic patients have an increased risk of developing cataract and develop cataract at an earlier age than patients without diabetes.1,4–8 In developed nations, 11–25% of all cataract surgery is performed in patients with diabetes and 1.2–5.0% of these patients will have concomitant diabetic retinopathy.7,9–13 Thus, cataract surgery in patients with diabetes and with diabetic retinopathy is common, yet the interactions of cataract surgery and the diabetic eye are incompletely understood and a subject of controversy.

Keywords

Optical Coherence Tomography Diabetic Retinopathy Cataract Surgery Macular Edema Diabetic Macular Edema 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Dowler J, Hykin PG. Cataract surgery in diabetics. Curr Opin Ophthalmol. 2001;12:175–178.PubMedGoogle Scholar
  2. 2.
    Williams R, Airey M, Baxter H, et al. Epidemiology of diabetic retinopathy and macular edema: a systematic review. Eye. 2004;18(963):983.Google Scholar
  3. 3.
    US Diabetes Prevalence. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2005.pdf9-20-2008. Accessed 9-20-2008.
  4. 4.
    Kleinbek R, Moss SE. Prevalence of cataracts in a population-based study of patients with diabetes mellitus. Ophthalmology. 1985;92:1191–1196.Google Scholar
  5. 5.
    Nielsen NV, Vinding T. The prevalence of cataract in insulin-dependent and non-insulin-dependent diabetes mellitus. Acta Ophthalmol Scand. 1984;62:595–602.Google Scholar
  6. 6.
    Ederer F, Hiller R, Taylor HR. Senile lens changes and diabetes in two population studies. Am J Ophthalmol. 1981;91:381–395.PubMedGoogle Scholar
  7. 7.
    Harding JJ, Egerton M, van Heyningen R, Harding RS. Diabetes, glaucoma, sex and cataract: analysis of combined data from two case control studies. Br J Ophthalmol. 1993;77:2–6.PubMedGoogle Scholar
  8. 8.
    Klein BE, Klein R, Wang Q, Moss SSE. Older-onset diabetes and lens opacities: the Beaver Dam Eye Study. Ophthalmic Epidemiol. 1995;2:49–55.PubMedGoogle Scholar
  9. 9.
    Squirrell D, Bhola R, Bush J, et al. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol. 2002;86:565–571.PubMedGoogle Scholar
  10. 10.
    Suto C, Hori S, Kato S. Management of type 2 diabetics requiring panretinal photocoagulation and cataract surgery. J Cataract Refract Surg. 2008;34:1001–1006.PubMedGoogle Scholar
  11. 11.
    The Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122:552–563.Google Scholar
  12. 12.
    Royal College of Ophthalmologists. Cataract Surgery Guidelines. 2004. http://www.rcophth.ac.uk/docs/publications/CataractSurgeryGuidelinesMarch2005Updated.pdf. Accessed 9-20-2008.
  13. 13.
    Flanagan DW. Progression of diabetic retinopathy following cataract surgery: can it be prevented? Br J Ophthalmol. 1996;80:777–779.Google Scholar
  14. 14.
    Schein OD, Steinberg EP, Javitt JC, et al. Variation in cataract surgery practice and clinical outcomes. Ophthalmology. 1994;101:1142–1152.PubMedGoogle Scholar
  15. 15.
    Straatsma BR, Pettit TH, Wheeler N, Miyamasu W. Diabetes and intraocular lens implantation. Ophthalmology. 1983;90:336–343.PubMedGoogle Scholar
  16. 16.
    Cunliffe IA, Flanagan DW, George NDL, et al. Extracapsular cataract surgery with lens implantation in diabetics with and without proliferative retinopathy. Br J Ophthalmol. 1991;75:9–12.PubMedGoogle Scholar
  17. 17.
    Zaczek A, Olivestedt G, Zetterstrom C. Visual outcome after phacoemulsification and IOL implantation in diabetic patients. Br J Ophthalmol. 1999;83:1036–1041.PubMedGoogle Scholar
  18. 18.
    Shah DP, Krishnan AA, Albanis CV, et al. Visual acuity outcomes following vitreous loss in glaucoma and diabetic patients. Eye. 2002;16:271–274.PubMedGoogle Scholar
  19. 19.
    Wagner T, Knaflic D, Rauber M, Mester U. Influence of cataract surgery of the diabetic eye: a prospective study. German J Ophthalmol. 1996;5:79–83.Google Scholar
  20. 20.
    Benson WE, Brown GC, Tasman W, et al. Extracapsular cataract extraction with placement of a posterior chamber lens in patients with diabetic retinopathy. Ophthalmology. 1993;100:730–738.PubMedGoogle Scholar
  21. 21.
    Sebestyen JG, Wafai MZ. Experience with intraocular lens implants in patients with diabetes. Am J Ophthalmol. 1983;96:94–96.PubMedGoogle Scholar
  22. 22.
    Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy IV. Diabetic macular edema. Ophthalmology. 1984;91:1464–1474.PubMedGoogle Scholar
  23. 23.
    Mittra RA, Borrillo JL, Dev S, et al. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol. 2000;118:912–917.PubMedGoogle Scholar
  24. 24.
    Chiu DW, Meusemann RA, Kaufman DV, et al. Visual outcome and progression of retinopathy after cataract surgery in diabetic patients. Austral NZ J Ophthalmol. 26:129–133.Google Scholar
  25. 25.
    Hykin PG, Gregson RMC, Stevens JD, Hamilton PAM. Extracapsular cataract extraction in proliferative diabetic retinopathy. Ophthalmology. 1993;100:394–399.PubMedGoogle Scholar
  26. 26.
    Ruiz RS, Saatci OA. Posterior chamber intraocular lens implantation in eyes with inactive and active proliferative diabetic retinopathy. Am J Ophthalmol. 1991;111:158–162.PubMedGoogle Scholar
  27. 27.
    Dowler JGF, Hykin PG, Lightman SL, Hamilton AM. Visual acuity following extracapsular cataract extraction in diabetes: a meta-analysis. Eye. 1995;9:313–317.PubMedGoogle Scholar
  28. 28.
    Ebihara Y, Kato S, Oshika T, et al. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. J Cataract Refract Surg. 2006;32:1184–1187.PubMedGoogle Scholar
  29. 29.
    Lee JS, Lee JE, Choi HY, et al. Corneal endothelial cell change after phacoemulsification relative to the severity of diabetic retinopathy. J Cataract Ref Surg. 2005;31:742–749.Google Scholar
  30. 30.
    Romero-Aroca P, Fernandez-Ballart J, Almena-Garcia M, et al. Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: prospective study. J Cataract Refract Surg. 2006;32:1438–1444.PubMedGoogle Scholar
  31. 31.
    Ionides A, Dowler JG, Hykin PG, et al. Posterior capsular opacification following diabetic extracapsular cataract extraction. Eye. 1994;8:535–537.PubMedGoogle Scholar
  32. 32.
    Zaczek A, Zetterstrom C. Aqueous flare intensity after phacoemulsification in patients with diabetes mellitus. Cataract Refract Surg. 1998;24:1099–1106.Google Scholar
  33. 33.
    Tennant MTS, Connolly BP. Cataract surgery in patients with retinal disease. Curr Opin Ophthalmol. 2002;13:19–23.PubMedGoogle Scholar
  34. 34.
    Kodama T, Hayasaka S, Setogawa T. Plasma glucose levels, postoperative complications, and progression of retinopathy in diabetic patients undergoing intraocular lens implantation. Graefe's Arch Clin Exp Ophthalmol. 1993;231:439–443.Google Scholar
  35. 35.
    Krupsky S, Zalish M, Oliver M, Pollack A. Anterior segment complications in diabetic patients following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Ophthalmic Surg. 1991;22:526–530.PubMedGoogle Scholar
  36. 36.
    Fineman MS, Benson WE. Cataract surgery in patients with diabetes mellitus. Comp Ophthalmol Update. 2000;1:259–269.Google Scholar
  37. 37.
    Dowler JGF, Hykin PG, Hamilton AMP. Phacoemulsification versus extracapsular cataract extraction in patients with diabetes. Ophthalmology. 2000;107:457–462.PubMedGoogle Scholar
  38. 38.
    Moriarty AP, Spalton DJ, Moriarty BJ, et al. Studies of the blood-aqueous barrier in diabetes mellitus. Am J Ophthalmol. 1994;117:766–771.Google Scholar
  39. 39.
    Menchini U, Azzolini C, Camesasca FI, Brancato R. Combined vitrectomy, cataract extraction, and posterior chamber intraocular lens implantation in diabetic patients. Ophthalmic Surg. 1991;22:69–73.PubMedGoogle Scholar
  40. 40.
    Jaffe GJ, Burton TC, Kuhn E, et al. Reply to Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol. 1993;115:401–402.Google Scholar
  41. 41.
    Benson WE. Cataract surgery and diabetic retinopathy. Curr Opin Ophthalmol. 1992;3:396–400.PubMedGoogle Scholar
  42. 42.
    Apple DJ, Federman JL, Krolicki TJ, et al. Irreversible silicone oil adhesion to silicone lenses. A clinicopathologic analysis. Ophthalmology. 1996;103:1555–1561.PubMedGoogle Scholar
  43. 43.
    Pavese T, Insler MS. Effects of extracapsular cataract extraction with posterior chamber lens implantation on the development of neovascular glaucoma in diabetics. J Cataract Ref Surg. 1987;13:197–201.Google Scholar
  44. 44.
    Aiello LM, Wand M, Liang G. Neovascular glaucoma and vitreous hemorrhage following cataract surgery in patients with diabetes mellitus. Ophthalmology. 1983;90:814–820.PubMedGoogle Scholar
  45. 45.
    Prasad P, Setna PH, Dunne JA. Accelerated ocular neovascularisation in diabetics following posterior chamber lens implantation. Br J Ophthalmol. 1990;74:313–314.PubMedGoogle Scholar
  46. 46.
    Parodi MB, Iacono P. Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma. Am J Ophthalmol. 2004;138:157–158.PubMedGoogle Scholar
  47. 47.
    Kubota T, Tawara A, Hata T, et al. Neovascular tissue in the intertrabecular spaces in eyes with neovascular glaucoma. Br J Ophthalmology. 1996;80:750–754.Google Scholar
  48. 48.
    Coyle JT. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol. 1993;115:824–825.PubMedGoogle Scholar
  49. 49.
    Poliner L, Christianson D, Escoffery R, et al. Neovascular glaucoma after intracapsular and extracapsular cataract extraction in diabetic patients. Am J Ophthalmol. 1985;100:637–643.PubMedGoogle Scholar
  50. 50.
    Rice TA, Michels RG, Maguire MG, Rice EF. The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy. Am J Ophthalmol. 1983;95:1–11.PubMedGoogle Scholar
  51. 51.
    Oshima Y, Sakaguchi H, Gomi F, Tano Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2006;142:155–158.PubMedGoogle Scholar
  52. 52.
    Eren E, Kucukerdonmez C, YIlmaz G, Akova YA. Regression of neovascular posterior capsule vessels by intravitreal bevacizumab. J Cataract Ref Surg. 2007;33:1113–1115.Google Scholar
  53. 53.
    Blankenship G, Machemer R. Long-term diabetic vitrectomy results: report of 10 year follow-up. Ophthalmology. 1985;92:503–506.Google Scholar
  54. 54.
    Hutton WL, Pesicka GA, Fuller DW. Cataract extraction in the diabetic eye after vitrectomy. Am J Ophthalmol. 1987;104:1–4.PubMedGoogle Scholar
  55. 55.
    Grusha YO, Masket S, Miller KM. Phacoemulsification and lens implantation after pars plana vitrectomy. Ophthalmology. 1998;105:287–294.PubMedGoogle Scholar
  56. 56.
    Spaide RF, Fisher YL. Intravitreal Bevacizumab (Avastin) Treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 2006;26:275–278.PubMedGoogle Scholar
  57. 57.
    Mason JO III, Nixon PA, White MF. Intravitreal injection of bevacizumab (avastin) as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol. 2006;142:685–688.PubMedGoogle Scholar
  58. 58.
    Chew EY, Benson WE, Remaley NA, et al. Results after lens extraction in patients with diabetic retinopathy-Early treatment diabetic retinopathy study report number 25. Arch Ophthalmol. 1999;117:1600–1606.Google Scholar
  59. 59.
    Pollack A, Leiba H, Oliver M. Cystoid macular oedema following cataract extraction in patients with diabetes. Br J Ophthalmol. 1992;76:221–224.PubMedGoogle Scholar
  60. 60.
    Chung J, Kim MY, Kim HS, et al. Effect of cataract surgery on the progression of diabetic retinopathy. J Cataract Refract Surg. 2002;25:626–630.Google Scholar
  61. 61.
    Dev S, Pulido JS, Tessler HH, et al. Progression of diabetic retinopathy after endophthalmitis. Ophthalmology. 1999;106:774–781.PubMedGoogle Scholar
  62. 62.
    Chatterjee S, Savant VV, Stavrou P. Diabetic retinopathy progression and visual outcome after phacoemulsification in South-Asian and Afro-Caribbean patients with diabetes. Eye. 2004;18:575–579.PubMedGoogle Scholar
  63. 63.
    Flesner P, Sander B, Henning V, et al. Cataract surgery on diabetic patients. A prospective evaluation of risk factors and complications. Acta Ophthalmol Scand. 2002;80:19–24.PubMedGoogle Scholar
  64. 64.
    Pollack A, Dotan S, Oliver M. Course of diabetic retinopathy following cataract surgery. Br J Ophthalmol. 1991;75:2–8.PubMedGoogle Scholar
  65. 65.
    Schatz H, Atienza D, McDonald HR, Johnson RN. Severe diabetic retinopathy after cataract surgery. Am J Ophthalmol. 1994;117:314–321.PubMedGoogle Scholar
  66. 66.
    Pollack A, Dotan S, Oliver M. Progression of diabetic retinopathy after cataract extraction. Br J Ophthalmol. 1991;75:547–551.PubMedGoogle Scholar
  67. 67.
    Hauser D, Katz H, Pokroy R, et al. Occurrence and progression of diabetic retinopathy after phacoemulsification cataract surgery. J Cataract Refract Surg. 2004;30:428–432.PubMedGoogle Scholar
  68. 68.
    Dowler JGF, Sehmi KS, Hykin PG, Hamilton AMP. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology. 1999;106:663–668.PubMedGoogle Scholar
  69. 69.
    Kurtschan A, Heinz P, Wiegand W. Extrakapsulare kataraktoperation mittels kernexpression mit hinterkammerlinsenimplantation bei patienten mit diabetes mellitus – eine retrospektive studie an 145 patienten. Klin Monatsnl Augenheilkd. 2002;219:117–124.Google Scholar
  70. 70.
    Escaravage GK, Cohen KL, Patel SB, et al. Quantification of macular and optic disc hyperfluorescence after phacoemulsification in diabetes mellitus. J Cataract Refract Surg. 2006;32:803–811.PubMedGoogle Scholar
  71. 71.
    Patz A. Photocoagulation of retinal, vascular, and macular diseases through intraocular lenses. Ophthalmology. 1981;88:398–406.PubMedGoogle Scholar
  72. 72.
    Levin ML, Kincaid MC, Eifler CW, et al. Effect of cataract surgery and intraocular lenses on diabetic retinopathy. J Cataract Refract Surg. 1998;14:642–649.Google Scholar
  73. 73.
    Henricsson M, Heijl A, Janzon L. Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol. 1996;80:789–793.PubMedGoogle Scholar
  74. 74.
    Bressler NM, Bressler SB. Exacerbation of diabetic macular edema after cataract surgery. The Wilmer Retina Update. 1996;2:69–85.Google Scholar
  75. 75.
    Cheema RA, Al-Mubarak MM, Amin YM, Cheema MA. Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy. A prospective randomized study. J Cataract Refract Surg. 2009;35:18–25.PubMedGoogle Scholar
  76. 76.
    Jaffe GJ, Burton TC, Kuhn E, et al. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol. 1992;114:448–456.PubMedGoogle Scholar
  77. 77.
    Kim SY, Yang J, Lee YC, Park YH. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery. J Cataract Refract Surg. 2008;34:823–826.PubMedGoogle Scholar
  78. 78.
    Suto C, Hori S, Kato S, et al. Effect of perioperative glycemic control in progression of diabetic retinopathy and maculopathy. Arch Ophthalmol. 2008;124:38–45.Google Scholar
  79. 79.
    Jaffe GJ, Burton TC. Progression of nonproliferative diabetic retinopathy following cataract extraction. Arch Ophthalmol. 1988;106:745–749.PubMedGoogle Scholar
  80. 80.
    Henderson BA, Kim JY, Ament CS, et al. Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment. J Cataract Refract Surg. 2007;33:1550–1558.PubMedGoogle Scholar
  81. 81.
    Degenring RF, Vey S, Kamppeter B, et al. Effect of uncomplicated phacoemulsification on the central retina in diabetic and non-diabetic subjects. Graefes Arch Clin Exp Ophthalmol. 2007;245:18–23.PubMedGoogle Scholar
  82. 82.
    Johnson MW. Etiology and treatment of macular edema. Am J Ophthalmol. 2009;147:11–21.PubMedGoogle Scholar
  83. 83.
    Gass JDM, Norton EWD. Cystoid macular edema and papilledema following cataract extraction: a fluorescein funduscopic and angiographic study. Arch Ophthalmol. 1966;76:396–400.Google Scholar
  84. 84.
    Stark WJ J, Maumenee AE, Fagadau W, et al. Cystoid macular edema in pseudophakia. Surv Ophthalmol. 1984;28:442–451.PubMedGoogle Scholar
  85. 85.
    Lee YC, Chung FL, Chen CC. Intraocular pressure and foveal thickness after phacoemulsification. Am J Ophthalmol. 2007;144:203–208.PubMedGoogle Scholar
  86. 86.
    von Jagow B, Ohrloff C, Kohnen T. Macular thickness after uneventful cataract surgery determined by optical coherence tomography. Graefe's Arch Clin Exp Ophthalmol. 2007;245:1765–1771.Google Scholar
  87. 87.
    Lobo CL, Faria PM, Soares MA, et al. Macular alterations after small-incision cataract surgery. J Cataract Refract Surg. 2004;30:752–760.PubMedGoogle Scholar
  88. 88.
    Alpar JJ. Diabetes: cataract extraction and intraocular lens. J Cataract Refract Surg. 1987;13:43–46.PubMedGoogle Scholar
  89. 89.
    Menchini U, Cappelli S, Virgili G. Cataract surgery and diabetic retinopathy. Semin Ophthalmol. 2003;18:103–108.PubMedGoogle Scholar
  90. 90.
    Menchini U, Bandello F, Brancato R, et al. Cystoid macular oedema after extracapsular cataract extraction and intraocular lens implantation in diabetic patients without retinopathy. Br J Ophthalmol. 1993;77:208–211.PubMedGoogle Scholar
  91. 91.
    Nelson ML, Martidis A. Managing cystoid macular edema after cataract surgery. Curr Opin Ophthalmol. 2003;14:39–43.PubMedGoogle Scholar
  92. 92.
    Lobo CL, Bernardes RC, Cunha-Vaz JG. Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes. Arch Ophthalmol. 2000;118:1364–1369.PubMedGoogle Scholar
  93. 93.
    Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology. 2007;114:881–889.PubMedGoogle Scholar
  94. 94.
    Laurell CG, Zetterstrom C, Lundgren B, et al. Inflammatory response in the rabbit after phacoemulsification and intraocular lens implantation using a 5.2 or 11.0 mm incision. J Cataract Ref Surg. 1997;23:126–131.Google Scholar
  95. 95.
    Shimura M, Nakazawa T, Yasuda K, Nishida K. Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes. J Ocul Pharmacol Ther. 2007;23:284–291.PubMedGoogle Scholar
  96. 96.
    Browning DJ. Diabetic macular edema: a critical review of the early treatment diabetic retinopathy study (ETDRS) series and subsequent studies. Comp Ophthalmol Update. 2000;1:69–83.Google Scholar
  97. 97.
    Gillies MC, Sutter FK, Simpson JM, et al. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology. 2006;113:1533–1538.PubMedGoogle Scholar
  98. 98.
    Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115:1447–1459.Google Scholar
  99. 99.
    Arevalo JF, Garcia-Amaris RA, Roca JA, et al. Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema: pilot study of the Pan-American Collaborative Retina Study Group. J Cataract Refract Surg. 2007;33:2098–2105.PubMedGoogle Scholar
  100. 100.
    Mason JO III, Albert MA Jr, Vail R. Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina. 2006;26:356–358.PubMedGoogle Scholar
  101. 101.
    Cervera E, Diaz-Llopis M, Udaondo P, Garcia-Delpech S. Intravitreal pegaptanib sodium for refractory pseudophakic macular edema. Eye. 2008;22:1180–1182.PubMedGoogle Scholar
  102. 102.
    Hayashi K, Igarashi C, Hirata A, Hayashi H. Changes in diabetic macular oedema after phacoemulsification surgery [epub ahead of print] [Record Supplied By Publisher]. Eye. 2007;23:389–396.Google Scholar
  103. 103.
    Gupta A, Gupta V. Diabetic maculopathy and cataract surgery. Ophthalmol Clin North Am. 2001;14:625–637.PubMedGoogle Scholar
  104. 104.
    Browning DJ, McOwen MD, Bowen RM Jr, O'Marah TL. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology. 2004;111:712–715.PubMedGoogle Scholar
  105. 105.
    Brown JC, Solomon SD, Bressler SB, et al. Detection of diabetic foveal edema; contact lens biomicroscopy compared with optical coherence tomography. Arch Ophthalmol. 2004;122:330–335.PubMedGoogle Scholar
  106. 106.
    Lam DS, Chan CK, Mohamed S, et al. Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study. Eye. 2005;19:885–890.PubMedGoogle Scholar
  107. 107.
    Bandello F, Brancato R, Lattanzio R, et al. Relation between iridopathy and retinopathy in diabetes. Br J Ophthalmology. 1994;78:542–545.Google Scholar
  108. 108.
    Mackool RJ. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol. 1993;115:400–401.PubMedGoogle Scholar
  109. 109.
    Browning DJ, Zhang Z, Benfield JM. The effect of patient characteristics on response to focal laser treatment for diabetic macular edema. Ophthalmology. 1997;104:466–472.PubMedGoogle Scholar
  110. 110.
    Hariprasad SM, Callanan D, Gainey S, et al. Cystoid and diabetic macular edema treated with nepafenac 0.1%. J Ocul Pharmacol Ther. 2007;23:585–590.PubMedGoogle Scholar
  111. 111.
    McCarty CA, Wright S, McKay R, et al. Changes in management of diabetic retinopathy by Australian ophthalmologists as a result of the NHMRC clinical guidelines. Clinical and Exp Ophthalmol. 2001;29:230–234.Google Scholar
  112. 112.
    Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for Diabetic Macular Edema. Arch Ophthalmol. 1985;103:1796–1806.Google Scholar
  113. 113.
    Tunc M, Onder HI, Kaya M. Posterior sub-tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema. Ophthalmology. 2005;112:1086–1091.PubMedGoogle Scholar
  114. 114.
    Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109:920–927.PubMedGoogle Scholar
  115. 115.
    Lewis H. The role of vitrectomy in the treatment of diabetic macular edema. Am J Ophthalmol. 2001;131:123–125.PubMedGoogle Scholar
  116. 116.
    Browning DJ, Fraser CM, Powers ME. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application. Ophthalmology. 2006;113:1713–1719.PubMedGoogle Scholar
  117. 117.
    Mamalis N, Teske MP, Kreisler KR, et al. Phacoemulsification combined with pars plana vitrectomy. Ophthalmic Surg. 1991;22:194–198.PubMedGoogle Scholar
  118. 118.
    Lahey JM, Francis RR, Kearney JJ. Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy; a series of 223 cases. Ophthalmology. 2003;110:1335–1339.PubMedGoogle Scholar
  119. 119.
    Koenig SB, Mieler WF, Han DP, Abrams GW. Combined phacoemulsification, pars plana vitrectomy, and posterior chamber intraocular lens insertion. Arch Ophthalmol. 1992;110:1101–1104.PubMedGoogle Scholar
  120. 120.
    Benson W, Brown G, Tasman W, McNamara J. Extracapsular cataract extraction, posterior chamber lens insertion, and pars plana vitrectomy in one operation. Ophthalmology. 1990;97:918–921.PubMedGoogle Scholar
  121. 121.
    Blankenship GW, Flynn HW Jr, Kokame GT. Posterior chamber intraocular lens insertion during pars plana lensectomy and vitrectomy for complications of proliferative diabetic retinopathy. Am J Ophthalmol. 1989;108:1–5.PubMedGoogle Scholar
  122. 122.
    Schiff WM, Barile GR, Hwang JC, et al. Diabetic vitrectomy: influence of lens status upon anatomic and visual outcomes. Ophthalmology. 2007;114:544–550.PubMedGoogle Scholar
  123. 123.
    Smiddy WE, Feuer W. Incidence of cataract extraction after diabetic vitrectomy. Retina. 2004;24:574–581.PubMedGoogle Scholar
  124. 124.
    Montan PG, Koranyi G, Setterquist HE, et al. Endophthalmitis after cataract surgery: risk factors relating to technique and events of the operation and patient history-A retrospective case-control study. Ophthalmology. 1998;105:2171–2177.PubMedGoogle Scholar
  125. 125.
    Doft B, Wisniewski SR, Kelsey SF, et al. Diabetes and postoperative endophthalmitis in the endophthalmitis vitrectomy study. Arch Ophthalmol. 2001;119:650–656.PubMedGoogle Scholar
  126. 126.
    Doft BH, Wisniewski SR, Kelsey SF, et al. Diabetes and postoperative endophthalmitis in the endophthalmitis vitrectomy study. Arch Ophthalmol. 2001;119:650–656.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Charlotte Eye Ear Nose & Throat AssociatesCharlotteUSA

Personalised recommendations